Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Inhibitors >  Angiogenesis >  Syk inhibitors >  Fostamatinib

Fostamatinib

Basic information Safety Supplier Related

Fostamatinib Basic information

Product Name:
Fostamatinib
Synonyms:
  • Fostamatinib
  • FostaMatinib DisodiuM
  • FostaMatinib (R788)
  • R788
  • NSC-745942
  • R-935788
  • R7935788
  • 6-[[5-Fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-4-[(phosphonooxy)methyl]-2H-pyrido[3,2-b]-1,4-oxazin-3(4H)-one
CAS:
901119-35-5
MF:
C23H26FN6O9P
MW:
580.46
EINECS:
618-473-2
Product Categories:
  • Inhibitors
  • API
Mol File:
901119-35-5.mol
More
Less

Fostamatinib Chemical Properties

Melting point:
214° - 217°C
Boiling point:
814.2±75.0 °C(Predicted)
Density 
1.496
storage temp. 
-20°C, Hygroscopic
solubility 
DMSO (Slightly), Methanol (Slightly)
pka
1.70±0.10(Predicted)
form 
Solid
color 
White to Off-White
Stability:
Hygroscopic
More
Less

Fostamatinib Usage And Synthesis

Uses

Fostamatinib can be used to treat cancers that have acquired resistance to kinase inhibitors.

Biological Activity

fostamatinib is a small molecule inhibitor of spleen tyrosine kinase (syk) with ic50 value of 41nm [1].fostamatinib is an orally bioavailable prodrug of r406. it is developed for the treatment of autoimmune diseases. the effective metabolite of fostamatinib, r406, is an atp-competitive inhibitor of syk with ki value of 30nm. r406 also inhibits the activity of other kinases including flt3, lyn (ic50=63nm) and lck (ic50=37nm). it is found that r406 inhibits both bcr and fcr mediated responses in vitro. besides that, r406 also shows effects in other cells types and signalling pathways. in the in vivo assay, fostamatinib shows to be highly active to inhibit fcr-mediated signaling in various animal models of allergy, autoimmunity and inflammation. moreover, fostamatinib also exerts efficacy in sle animal models. treatment of fostamatinib suppresses the established renal and skin disease and reduces lymphadenopathy in the mrl/lpr strain [1].

References

[1] mcadoo s p, tam f w k. fostamatinib disodium. drugs of the future, 2011, 36(4): 273.

FostamatinibSupplier

Anqing Runke Biomedical Technology Co., Ltd. Gold
Tel
0556-5282330 18075373931
Email
sales@growingchem.com
Chuzhou KeMail Chemical Technology Co., Ltd Gold
Tel
0550-5196001 15000891977
Email
wj520wjxby@126.com
Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
Chembest Research Laboratories Limited
Tel
021-20908456
Email
sales@BioChemBest.com
BeiJing Hwrk Chemicals Limted
Tel
0757-86329057 18501085097
Email
sales3.gd@hwrkchemical.com